Key result
Discontinuation of the triggering anesthetic agent and active cooling successfully resolved suspected malignant hyperthermia in a 20-year-old male without the use of dantrolene.
Case Report (n=1)
No
Answers are grounded in this paper and cite their sources.
This case report highlights the rare but potentially lethal occurrence of malignant hyperthermia during surgery, emphasizing the need for immediate recognition and treatment.
Malignant hyperthermia is an extremely rare, potentially lethal disorder that occurs in susceptible patients who are exposed to triggering agents such as volatile anesthetic gases or depolarizing muscle relaxants. The clinical manifestations of malignant hyperthermia include hypermetabolism, hyperthermia, hypercapnia, and sustained skeletal muscle rigidity, which result in cardiac arrest, brain damage, and death. It is associated with a high morbidity and mortality rate if not recognized immediately and treated appropriately. We report a case of suspected malignant hyperthermia in a young male patient undergoing axillary osmidrosis surgery.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2022) conducted a case report in Malignant hyperthermia (n=1). Discontinuation of triggering agents and active cooling was evaluated on Clinical recovery from malignant hyperthermia crisis. Discontinuation of the triggering anesthetic agent and active cooling successfully resolved suspected malignant hyperthermia in a 20-year-old male without the use of dantrolene.
Synapse has enriched 10 related papers. Consider them for comparative context: